Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center
Agenus Inc.
City of Hope Medical Center
National Cancer Institute (NCI)
Monte Rosa Therapeutics, Inc
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Duke University
AstraZeneca
Complement Theory Inc.
NeoTX Therapeutics Ltd.
UNICANCER
Pfizer
Sensei Biotherapeutics, Inc.
OncoC4, Inc.
Tempus AI
N.N. Petrov National Medical Research Center of Oncology
Theratechnologies
Carisma Therapeutics Inc
NGM Biopharmaceuticals, Inc
Intuitive Surgical